GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

GETI.B

202

+0.65%↑

CAMX

669

+0.22%↑

EKTA.B

47.08

-0.08%↓

VITR

129

+0.31%↑

AMBEA

132.4

+0.38%↑

Inicio・Lista de Acciones・BioArctic AB

B
BioArctic AB

Cerrado

284.6 -2.47

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

284.2

Máximo

285.2

Métricas clave
By Trading Economics
Ingresos	-896M 179M
Ventas	-897M 392M
P/B Media del Sector	23.701 35.69
BPA	1.09
Margen de beneficios	45.668
Empleados	119
EBITDA	-893M 188M

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	4.5B 25B
Apertura anterior	287.07
Cierre anterior	284.6

BioArctic AB Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

26 sept 2025, 18:25 UTC

Principales Movimientos del Mercado

Mirion Technologies Stock Rises on Expanded Notes, Shares Offerings

27 sept 2025, 07:00 UTC

Ganancias

This Water Stock Is Dehydrated. What Could Bring It Back. -- Barrons.com

27 sept 2025, 04:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

26 sept 2025, 21:56 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical, Insight Enterprises, and More Stocks See Action From Activist Investors -- Barrons.com

26 sept 2025, 20:54 UTC

Ganancias

U.S. TikTok for $14 Billion? Making Sense of the Bargain-Basement Price. -- Barrons.com

26 sept 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

26 sept 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

26 sept 2025, 20:27 UTC

Adquisiciones, fusiones, absorciones

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 sept 2025, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

26 sept 2025, 19:54 UTC

Charlas de Mercado

Canada's Can't-Build Reputation Is Somewhat Earned -- Market Talk

26 sept 2025, 19:53 UTC

Adquisiciones, fusiones, absorciones

Electronic Arts Stock Pops on Report Videogame Maker Is Close to Going Private -- Barrons.com

26 sept 2025, 19:40 UTC

Ganancias

The U.S. TikTok Is Apparently Fetching a Bargain-Basement Price. A Few Reasons Why. -- Barrons.com

26 sept 2025, 19:24 UTC

Charlas de Mercado

U.S. Natural Gas Futures Mixed As October Expires -- Market Talk

26 sept 2025, 19:17 UTC

Charlas de Mercado

Oil Posts Weekly Gains on Russia-Ukraine Tensions -- Market Talk

26 sept 2025, 19:15 UTC

Charlas de Mercado

AI Deployment Beginning to Weigh on Job Creation, Former Central Banker Says -- Market Talk

26 sept 2025, 19:03 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

26 sept 2025, 19:03 UTC

Charlas de Mercado

Gold Fuels Stellar Performance in Toronto Stock Market -- Market Talk

26 sept 2025, 18:50 UTC

Charlas de Mercado

Ganancias

Costco's Executive Membership Gains Seen as Offsetting Slower Renewal Rates -- Market Talk

26 sept 2025, 18:36 UTC

Charlas de Mercado

Silver Closes Out Week With Strong Surge -- Market Talk

26 sept 2025, 18:02 UTC

Adquisiciones, fusiones, absorciones

ING: Continue Working Towards Completing Transaction, Exit From Russian Market >ING

26 sept 2025, 18:02 UTC

Adquisiciones, fusiones, absorciones

ING: Global Development Hasn't Received All Necessary Approvals >ING

26 sept 2025, 18:02 UTC

Adquisiciones, fusiones, absorciones

ING: No Realistic Prospect of Completing Sale of ING Bank (Eurasia) to Global Development in 3Q

26 sept 2025, 17:54 UTC

Charlas de Mercado

U.S. Oil Rig Count Rises For Fifth Straight Week -- Market Talk

26 sept 2025, 16:56 UTC

Charlas de Mercado

Ganancias

Costco Increasingly Challenged to Meet Lofty Expectations -- Market Talk

26 sept 2025, 16:41 UTC

Charlas de Mercado

Ganancias

Costco's Valuation Seen as Too High Amid Slow Down -- Market Talk

26 sept 2025, 16:26 UTC

Ganancias

Correction to Sherwin-Williams Extends Losses. What's Ailing the Paint Maker. -- Barrons.com

26 sept 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

26 sept 2025, 16:12 UTC

Charlas de Mercado

Nike Stock Seen With Limited Upside -- Market Talk

26 sept 2025, 15:59 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

26 sept 2025, 15:59 UTC

Charlas de Mercado

Nike Seen Showing Progress in Turnaround -- Market Talk

Comparación entre iguales

Cambio de precio

BioArctic AB previsión

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.